Performance, page-7

Desco is bang on.

But the usual excuses and beliefs are here - confidentiality, manipulators, and abdm is the super-researcher.

How can confidentiality be an excuse here? Management is treating shareholders like mushrooms. It's so obvious. Look for ways in which confidentiality is not relevant in this case and you will see. It is possible to look at the other side of the coin.

Manipulators are not keeping the price down. Reality is keeping the price down. Illusion was keeping the price up. I thought those milestones were already inevitable, but now management are telling us that they are not. Seems Hopeful2 was right.

I appreciate the good info provided by abdm. However, his original investment reasons and "research" were largely wrong. No patent cliff desperation from big pharma, no tripeptofen super drug with PNO, no immunisation deal, etc. The claims of people here about their own super-research leading to their current OBJ wealth are all rewriting of history. In reality, they were saved by P&G.